Resources
About Us
Home Report
Store
Bioinformatics Market
Bioinformatics Market Size, Share, Forecast, & Trends Analysis By Solutions & Services (Knowledge Management, Sequence Analysis, Data Analysis) Application (Genomics, Metabolomics, Transcriptomics) Industry (Health, Agriculture) – Global Forecast to 2031
Report ID:MRHC - 1041048 Pages: 198 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Bioinformatics Market was valued at $11.73 billion in 2023. This market is expected to reach $31.71 billion by 2031, from an estimated $13.15 billion in 2024, at a CAGR of 13.4% during the forecast period 2024-2031.
Bioinformatics Market Size & Forecast
The growth of this market is attributed to the growth of the biotech and pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules. Furthermore, untapped markets in emerging economies, growing clinical applications of genomic technologies, and the increasing use of bioinformatics in agriculture are expected to generate growth opportunities for the players operating in this market.
Bioinformatics Market Growth Drivers
Growth of the Biotechnology and Pharmaceutical Industries to Drive the Market
The demand for biopharmaceuticals is increasing globally. Biotech companies are focused on expanding their production capacities and capabilities to meet the increasing demand and develop new biopharmaceuticals. For instance, in April 2022, FUJIFILM Diosynth Biotechnologies (U.S.) expanded its BioProcess Innovation Center in Research Triangle Park (U.S.), with plans to equip the facility with analytical instrumentation, high-throughput bioprocessing equipment, and automation technologies.
Bioinformatics has many applications in biotechnology, including automatic genome sequencing, prediction of gene function and protein structure vaccine designing, phylogeny, gene identification, understanding gene and genome complexity, and protein structure, functionality, and folding. Similarly, pharmaceutical companies use bioinformatics throughout the drug discovery and development process. Identifying the drug target is a crucial step in the creation of new drugs. Moreover, bioinformatics tools are used for analyzing the data generated from preclinical and clinical trials as the amount of data generated is huge, and the integration of this generated biological data is necessary for the interpretation of results.
Click here to: Get Free Sample Pages of this Report
Initiatives Supporting Genomics Research Drives the Bioinformatics Market
Bioinformatics software helps researchers in analyzing and interpreting vast amounts of diverse genomic data. Bioinformatics is used in genomics for several applications, including genome assembly, functional genomics, comparative genomics, structural genomics, metagenomics, and cancer genomics. There has been a significant increase in funding for genomics research due to increased research activities, which has led to the development of advanced sequencing technologies and bioinformatics tools that have made it possible to analyze vast amounts of genomic data.
Genomics research is crucial in discovering new drugs, developing personalized medicines, and improving researchers’ understanding of disease mechanisms. Therefore, several private organizations and government entities are funding genomics research to improve patient outcomes and strengthen genomics infrastructures. For instance, in July 2021, the National Institutes of Health (U.S.) announced an investment of USD 80 million to support the establishment of the Mendelian Genomics Research Consortium and develop novel methods and approaches to aid researchers in identifying the genetic causes of single gene diseases. Such initiatives generate large amounts of genomics data for which bioinformatics tools are crucial to analyze and interpret this genomics data, driving the market growth.
Bioinformatics Market Trends
AI in Genomics and Sequence Analysis
The analysis of genomic data is a fundamental aspect of bioinformatics. With the advent of high-throughput sequencing technologies, the volume of genomic data has grown exponentially. AI techniques, particularly machine learning algorithms, have proven effective in tasks such as gene prediction, variant calling, and comparative genomics. Deep learning models, such as Convolutional Neural Networks (CNNs) and Recurrent Neural Networks (RNNs), have demonstrated remarkable performance in sequence analysis tasks, including predicting DNA motifs, transcription factor binding sites, and non-coding RNA elements. Pharmaceutical and genomics companies are collaborating to use AI in genomics and genetics. For instance, in November 2020, BioMarin Pharmaceutical Inc. (U.S.) and Deep Genomics (U.S.) entered into a preclinical collaboration to identify oligonucleotide drug candidates in four rare disease indications using The AI Workbench—Deep Genomics’ artificial intelligence drug discovery platform.
AI-driven Drug Discovery
The process of drug discovery is both time-consuming and costly. AI is transforming this process by accelerating the identification of potential drug candidates. Virtual screening, wherein AI algorithms predict the binding affinity of compounds to target proteins, has become an essential tool in drug discovery. Additionally, AI has enabled the repurposing of existing drugs for new therapeutic indications, a cost-effective approach to finding novel treatments for diseases. For instance, Insilico Medicine (U.S.) has developed PandaOmics, an AI-driven target discovery platform that uses deep learning models to identify therapeutic targets associated with a particular disease using a combination of omics data analysis, which is further put in the context of prior information obtained from publications, clinical trials, and grant applications.
Bioinformatics Market Opportunity
Growing Use of Bioinformatics in Agriculture Provides Opportunities for the Players Operating in the Market
Plant genomics research is often aimed at reducing the costs associated with producing crops, improving the safety and quality of the food supply, developing superior processing abilities, and enhancing the effectiveness and efficiency of plant breeding practices. These research studies aim to improve plant resistance to biotic and abiotic stress and increase the nutritional quality of plants.
The global population is increasing rapidly; however, agricultural output is decreasing due to environmental factors. Advancements in genomics and genetics are enabling researchers to study the effects of environmental factors on the genotypic and phenotypic traits of crops and livestock. Moreover, there is a need for improved seed and crop strains that are climate, disease, biotic, and abiotic stress-resistant and provide higher yields and better nutrition, which can be fulfilled by genetically engineering seeds and plants. Genomic research on plants generates vast amounts of data. Bioinformatics tools are used to accurately analyze and interpret this data. Additionally, bioinformatics tools are also used for gene discovery, enabling researchers to develop methods to improve seed quality and incorporate added micronutrients in the plants, benefiting human health.
Bioinformatics Market Analysis: Key Findings
By Solutions & Services: In 2024, the Knowledge Management Software Segment to Dominate the Bioinformatics Market
Based on solutions & services, the bioinformatics market is segmented into knowledge management software, bioinformatics platforms, and services. In 2024, the knowledge management software segment is expected to account for the largest share of 42.2% of the bioinformatics market. Expanding genomic datasets, growing adoption of precision medicine, growing investments in pharmaceutical R&D, and growing research in the application of genomics for several fields, including agriculture, clinical decision-making, and predictive medicine, support a large share of the segment.
The explosion of genomic, omics data, and clinical data has created a need for knowledge management solutions. These solutions integrate diverse data sources, including genomic sequences, experimental results, clinical records, and references from scientific literature, resulting in an integrated and accessible format for efficient data handling, organization, and analysis.
However, the bioinformatics platforms segment is expected to grow at the highest CAGR of 14.9% during the forecast period of 2024-2031. Bioinformatics platforms are essential tools for researchers, institutions, and organizations involved in life sciences, pharmaceuticals, and healthcare. Bioinformatics platforms provide a comprehensive suite of software, tools, and resources that empower scientists to extract meaningful insights from complex biological data, advancing research, drug discovery, and clinical applications. Bioinformatics platforms offer a wide range of functions and features that cater to the diverse needs of researchers and professionals across multiple domains, including genomics, proteomics, structural biology, and epidemiology, among others. The growing research and development activities in genomics, proteomics, structural biology, and epidemiology are expected to drive the segment growth.
By Application: in 2024, the Genomics Segment to Dominate the Global Bioinformatics Market
Based on application, the bioinformatics market is segmented into genomics, chemoinformatics, proteomics, transcriptomics, metabolomics, and other applications. In 2024, the genomics segment is expected to account for the largest share of 43.9% of the market. The factors contributing to the segment’s large share are the growing amount of genomics data being generated, the application of genomics in chronic disease management, and the growing prevalence of chronic diseases. A substantial amount of genomic data is generated every year due to advancements in sequencing technologies and research initiatives. For instance, according to the National Human Genome Research Institute (U.S.), around 40 exabytes of storage will be required to store the genome-sequence data generated worldwide by 2025. The data leads to more information about genetics to researchers, however, it also presents several challenges in terms of data storage, processing, analysis, and interpretation. This generates a demand for bioinformatics to process, analyze, and interpret large amounts of genomic data.
However, the proteomics segment is expected to grow at the highest CAGR of 15.5% during the forecast period of 2024-2031. The growing research activities to study proteins, the growing disease prevalence, and the need for new protein biomarkers drive the segment growth.
By Industry: in 2024, the Healthcare Segment to Dominate the Global Bioinformatics Market
Based on industry, the bioinformatics market is segmented into healthcare, agriculture, veterinary, and other industries. In 2024, the healthcare segment is expected to account for the largest share of the market. This segment's large market share is attributed to the wide applications of bioinformatics in the biotechnology and pharmaceutical industry, the growth of the pharmaceutical and biotech industry, and supportive initiatives for the growth of pharmaceutical and biotech companies. The rapid expansion and initiatives such as investments and provision of grants and funds to pharmaceutical and biotechnology companies for the manufacture and R&D of biopharmaceuticals are leading in demand for bioinformatics tools. For instance, in November 2021, Medical Research Agency (Poland) announced government funding of USD 73.3 million (PLN 300 million) for producing vaccines based on mRNA technology in Poland.
The healthcare segment is also expected to grow at a higher CAGR during the forecast period. The growth of this segment is attributed to the growing prevalence of diseases, the growth of biotech & pharmaceutical industries, and the need for the development of new drugs and biologics.
Geographical Analysis
Asia-Pacific: Fastest-Growing Regional Market
In 2024, North America is expected to account for 44.5% of the global bioinformatics market. The large share of North America is attributed to the favorable government initiatives for genomics research, growing applications of genomic research, declining cost of sequencing, increasing research investments by pharmaceutical and biopharmaceutical companies, and the growing adoption of precision cancer medicine supported by the increasing cancer prevalence.
However, Asia-Pacific is expected to record the highest CAGR of 14.3% during the forecast period of 2024 to 2031. The high growth of the Asia-Pacific bioinformatics market is attributed to the growing pharmaceutical and biotech industry, growth in genomics research, growing use of genetic engineering in the agriculture sector, and favorable government initiatives in Asian countries to develop novel bioinformatics tools.
The pharmaceutical companies in India are developing new chemical and biological entities. For instance, in 2023, the U.S. FDA accepted Glenmark Pharmaceuticals Limited’s (India) investigational new drug (IND) application for potential cancer drug GRC 54276. In addition, the Government of India, in its Union Budget 2023 presentation, advised pharmaceutical companies to focus on research and development. In 2023, the Central Drugs Standard Control Organisation announced that the government is planning to introduce a research-linked incentive program, such as the production-linked incentive (PLI) scheme, to boost research and development of pharmaceutical and biotech products in the country.
Bioinformatics Market: Key Companies
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in this market in the last three to four years. The key players profiled in the bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.).
Bioinformatics Industry Overview: Latest Developments from Key Industry Players
-
In June 2023, PerkinElmer Inc. (U.S.) launched Signals Research Suite, a unified, cloud-native SaaS platform. It integrates the Revvity Signals Notebook, VitroVivo, and Inventa applications.
-
In April 2022, PerkinElmer Inc. (U.S.) collaborated with Scitara Corporation (U.S.) for the integration of the PerkinElmer Signals Research Suite informatics platform with Scitara Scientific Integration Platform SIP.
- In April 2023, Agilent Technologies Inc. (U.S.) partnered with PathAI, Inc. (U.S.), an AI-powered research services and tools provider, to deliver a solution that combines PathAI’s algorithm development capabilities and Agilent’s assay development expertise.
Bioinformatics Market Research Summary
|
Particular |
Details |
|
Page No |
198 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
13.4% |
|
2031 Market Size (Value) |
$31.71 billion |
|
Segments Covered |
By Solutions & Services
By Application
By Industry
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LATAM), Middle East & Africa |
|
Key Companies |
Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.) |
Key questions answered in the bioinformatics market report:
The Bioinformatics Market involves the use of software and tools to analyze and interpret biological data, particularly genomic data. It supports advancements in fields like biotechnology, pharmaceuticals, and agriculture.
The Bioinformatics Market was valued at $11.73 billion in 2023 and is expected to grow to $31.71 billion by 2031.
The market is projected to expand from $13.15 billion in 2024 to $31.71 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period.
In 2024, the Bioinformatics Market size is estimated to be $13.15 Billion.
Key companies include Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Qiagen N.V., Agilent Technologies, Inc., Dassault Systèmes SE, Eurofins Genomic LLC, Revvity, Inc., Azenta, Inc., and DNAnexus, Inc.
The key players operating in the bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.).
Key trends include the integration of AI in genomics and sequence analysis, and AI-driven drug discovery, which is revolutionizing the drug development process.
The market growth is driven by advancements in biotechnology and pharmaceuticals, initiatives supporting genomics research, and increasing applications in drug development and agriculture.
Segments include solutions and services (knowledge management software, bioinformatics platforms, etc.), applications (genomics, proteomics, etc.), and industries (healthcare, agriculture, veterinary, etc.).
The Bioinformatics Market is expanding globally with North America currently holding the largest market share, while Asia-Pacific is expected to grow at the highest rate.
The market is growing robustly, driven by increased genomic research, rising applications in drug development, and advancements in bioinformatics tools.
The Bioinformatics Market is projected to grow at a CAGR of 13.4% from 2024 to 2031.
North America holds the largest market share, accounting for 44.5% of the global market in 2024.
1. Overview
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.1. Market Share Analysis
2.4. Assumptions For the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Drivers
4.2.1.1.1. Growth of the Biotech and Pharmaceutical Industries
4.2.1.1.2. Initiatives Supporting Genomics Research
4.2.1.1.3. Rising Need to Develop Novel Drugs/Drug Molecules
4.2.1.2. Restraints
4.2.1.2.1. Interoperability Limitations in Bioinformatics Analytical Platforms Due to Multiple Data Types
4.2.1.3. Opportunities
4.2.1.3.1. Untapped Markets in Emerging Economies
4.2.1.3.2. Growing Clinical Applications of Genomic Technologies
4.2.1.3.3. Increasing Use of Bioinformatics in Agriculture
4.2.1.4. Challenges
4.2.1.4.1. Shortage of Skilled Bioinformaticians
4.2.1.4.2. Data Privacy and Confidentiality Concerns
4.2.2. Factor Analysis
4.3. Trends
4.3.1. Integration of Artificial Intelligence (AI) and Machine Learning with Bioinformatics
4.3.1.1. AI in Genomics and Sequence Analysis
4.3.1.2. AI-driven Drug Discovery
4.3.1.3. Proteomics and AI Applications
4.3.1.4. AI for Personalized Medicine
4.4. Case Studies
4.4.1. Integration of the Client’s Multi-Disease Platform into A Single Solution
4.4.2. Provision of a Connected Analytic Solution for NGS Workflow Scaling Challenges
4.4.3. Facilitating Faster Processing and Lowering Plasmid Analysis Costs
4.5. Regulatory Analysis
5. Bioinformatics Market Assessment—by Solutions & Services
5.1. Overview
5.2. Knowledge Management Software
5.3. Bioinformatics Platforms
5.3.1. Sequence Analysis & Alignment Platforms
5.3.2. Functional & Structural Analysis Platforms
5.3.3. Other Bioinformatics Platforms
5.4. Services
5.4.1. Data Storage & Database Management Services
5.4.2. Data Analysis Services
6. Bioinformatics Market Assessment—by Application
6.1. Overview
6.2. Genomics
6.3. Chemoinformatics
6.4. Proteomics
6.5. Transcriptomics
6.6. Metabolomics
6.7. Other Applications
7. Bioinformatics Market Assessment—by Industry
7.1. Overview
7.2. Healthcare
7.3. Agriculture
7.4. Veterinary
7.5. Other Industries
8. Bioinformatics Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Rest Of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)
9.5.1. Thermo Fisher Scientific Inc. (U.S.)
9.5.2. Eurofins Genomics LLC (Germany)
9.5.3. Revvity, Inc. (U.S.)
9.5.4. Agilent Technologies, Inc. (U.S.)
9.5.5. Illumina, Inc. (U.S.)
9.5.6. F. Hoffmann–La Roche Ltd. (Switzerland)
9.5.7. Qiagen N.V. (Netherlands)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
10.1. Thermo Fisher Scientific, Inc.
10.2. Eurofins Genomics LLC (Subsidiary of Eurofins Scientific SE)
10.3. Revvity, Inc. (Previously Known as Perkinelmer, Inc.)
10.4. Agilent Technologies, Inc.
10.5. Illumina, Inc.
10.6. Qiagen N.V.
10.7. Dnanexus, Inc.
10.8. Dassault Systemes SE
10.9. Azenta, Inc.
10.10. F. Hoffmann-La Roche Ltd
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Investments and Funding to Support Genomics Research
Table 2 Bioinformatics: Standards and Compliance Guidelines
Table 3 Global Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 4 Global Bioinformatics Knowledge Management Software Market, By Country/Region, 2022–2031 (USD Million)
Table 5 Global Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 6 Global Bioinformatics Platforms Market, By Country/Region, 2022–2031 (USD Million)
Table 7 Global Sequence Analysis & Alignment Platforms Market, By Country/Region, 2022–2031 (USD Million)
Table 8 Global Functional & Structural Analysis Platforms Market, By Country/Region, 2022–2031 (USD Million)
Table 9 Global Other Bioinformatics Platforms Market, By Country/Region, 2022–2031 (USD Million)
Table 10 Global Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 11 Global Bioinformatics Services Market, By Country/Region, 2022–2031 (USD Million)
Table 12 Global Data Storage & Database Management Services Market, By Country/Region, 2022–2031 (USD Million)
Table 13 Global Data Analysis Services Market, By Country/Region, 2022–2031 (USD Million)
Table 14 Global Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 15 Global Bioinformatics Market for Genomics, By Country/Region, 2022–2031 (USD Million)
Table 16 Global Bioinformatics Market for Cheminformatics, By Country/Region, 2022–2031 (USD Million)
Table 17 Number of People with Diabetes Aged 20–79, By Region, 2021 Vs. 2030 Vs. 2045 (In Thousands)
Table 18 Global Bioinformatics Market for Proteomics, By Country/Region, 2022–2031 (USD Million)
Table 19 Estimated Number of New Cancer Cases, By Type (2020 Vs. 2030)
Table 20 Global Bioinformatics Market for Transcriptomics, By Country/Region, 2022–2031 (USD Million)
Table 21 Global Bioinformatics Market for Metabolomics, By Country/Region, 2022–2031 (USD Million)
Table 22 Global Bioinformatics Market for Other Applications, By Country/Region, 2022–2031 (USD Million)
Table 23 Global Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 24 Number of Clinical Trials 2019-2021
Table 25 Global Bioinformatics Market for Healthcare, By Country/Region, 2022–2031 (USD Million)
Table 26 Global Bioinformatics Market for Agriculture Industry, By Country/Region, 2022–2031 (USD Million)
Table 27 Global Meat Consumption by Type and Region, 2020 Vs. 2026 (Thousand Tonnes)
Table 28 Global Bioinformatics Market for Veterinary, By Country/Region, 2022–2031 (USD Million)
Table 29 Global Bioinformatics Market for Other Industries, By Country/Region, 2022–2031 (USD Million)
Table 30 Global Bioinformatics Market, By Country/Region, 2022–2031 (USD Million)
Table 31 North America: Bioinformatics Market, By Country, 2022–2031 (USD Million)
Table 32 North America: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 33 North America: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 34 North America: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 35 North America: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 36 North America: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 37 U.S.: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 38 U.S.: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 39 U.S.: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 40 U.S.: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 41 U.S.: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 42 Canada: Bioinformatics Market, By Solutions & Services, 2022–2031(USD Million)
Table 43 Canada: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 44 Canada: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 45 Canada: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 46 Canada: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 47 Europe: Bioinformatics Market, By Country/Region, 2022–2031 (USD Million)
Table 48 Europe: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 49 Europe: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 50 Europe: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 51 Europe: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 52 Europe: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 53 Germany: Bioinformatics Market, By Solutions & Services, 2022–2031(USD Million)
Table 54 Germany: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 55 Germany: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 56 Germany: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 57 Germany: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 58 France: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 59 France: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 60 France: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 61 France: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 62 France: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 63 U.K. Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 64 U.K. Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 65 U.K. Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 66 U.K. Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 67 U.K. Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 68 Italy: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 69 Italy: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 70 Italy: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 71 Italy: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 72 Italy: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 73 Spain: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 74 Spain: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 75 Spain: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 76 Spain: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 77 Spain: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 78 Estimated Number of New Cancer Cases, By Country, 2020 Vs. 2030
Table 79 Rest of Europe: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 80 Rest of Europe: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 81 Rest of Europe: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 82 Rest of Europe: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 83 Rest of Europe: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 84 Asia-Pacific: Bioinformatics Market, By Country/Region, 2022–2031 (USD Million)
Table 85 Asia-Pacific: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 86 Asia-Pacific: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 87 Asia-Pacific: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 88 Asia-Pacific: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 89 Asia-Pacific: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 90 China: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 91 China: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 92 China: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 93 China: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 94 China: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 95 India: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 96 India: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 97 India: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 98 India: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 99 India: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 100 Japan: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 101 Japan: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 102 Japan: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 103 Japan: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 104 Japan: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 105 Rest of Asia-Pacific: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 106 Rest of Asia-Pacific: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 107 Rest of Asia-Pacific: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 108 Rest of Asia-Pacific: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 109 Rest of Asia-Pacific: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 110 Latin America: Bioinformatics Market, By Country/Region, 2022–2031 (USD Million)
Table 111 Latin America: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 112 Latin America: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 113 Latin America: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 114 Latin America: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 115 Latin America: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 116 Brazil: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 117 Brazil: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 118 Brazil: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 119 Brazil: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 120 Brazil: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 121 Mexico: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 122 Mexico: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 123 Mexico: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 124 Mexico: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 125 Mexico: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 126 Rest of Latin America: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 127 Rest of Latin America: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 128 Rest of Latin America: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 129 Rest of Latin America: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 130 Rest of Latin America: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 131 Middle East & Africa: Bioinformatics Market, By Solutions & Services, 2022–2031 (USD Million)
Table 132 Middle East & Africa: Bioinformatics Platforms Market, By Type, 2022–2031 (USD Million)
Table 133 Middle East & Africa: Bioinformatics Services Market, By Type, 2022–2031 (USD Million)
Table 134 Middle East & Africa: Bioinformatics Market, By Application, 2022–2031 (USD Million)
Table 135 Middle East & Africa: Bioinformatics Market, By Industry, 2022–2031 (USD Million)
Table 136 Recent Developments, By Company, 2021-2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Bioinformatics Market, By Solution & Service, 2024 Vs. 2031 (USD Million)
Figure 8 Global Bioinformatics Market, By Application, 2024 Vs. 2031 (USD Million)
Figure 9 Global Bioinformatics Market, By Industry, 2024 Vs. 2031 (USD Million)
Figure 10 Global Bioinformatics Market, By Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 U.S.: Adoption of Genetically Engineered Crops, 2018 Vs. 2022
Figure 13 Pharmaceutical R&D Expenditures in The U.S., Europe, China, And Japan, 2010 Vs. 2021 (USD Billion)
Figure 14 U.S.: Number of Personalized Medicines on The Market, 2008-2020
Figure 15 Global Bioinformatics Market, By Solutions & Services, 2024 Vs. 2031 (USD Million)
Figure 16 Global Bioinformatics Market, By Application, 2024 Vs. 2031 (USD Million)
Figure 17 Applications of Metabolomics
Figure 18 Global Bioinformatics Market, By Industry, 2024 Vs. 2031 (USD Million)
Figure 19 Global Bioinformatics Market, By Geography, 2024 Vs. 2031 (USD Million)
Figure 20 North America: Bioinformatics Market Snapshot
Figure 21 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 22 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 23 Europe: Bioinformatics Market Snapshot
Figure 24 RoE: Pharmaceutical R&D Expenditure, 2020
Figure 25 Asia-Pacific: Bioinformatics Market Snapshot
Figure 26 Clinical Trial Activities in Malaysia, 2015-2025
Figure 27 Latin America: Bioinformatics Market Snapshot
Figure 28 Israel: National Committee for Transgenic Plants - Authorized Experiments, 2016-2021
Figure 29 Key Growth Strategies Adopted by Leading Players (2021–2024)
Figure 30 Bioinformatics Market: Competitive Benchmarking, By Solution & Services
Figure 31 Bioinformatics Market: Competitive Benchmarking, By Region
Figure 32 Competitive Dashboard Bioinformatics Market
Figure 33 Global Bioinformatics Market Share Analysis, By Key Players, 2023 (%)
Figure 34 Thermo Fisher Scientific, Inc.: Financial Overview (2023)
Figure 35 Eurofins Scientific SE.: Financial Overview (2023)
Figure 36 PerkinElmer, Inc.: Financial Overview (2023)
Figure 37 Agilent Technologies, Inc.: Financial Overview (2023)
Figure 38 Illumina, Inc.: Financial Overview (2023)
Figure 39 Qiagen N.V.: Financial Overview (2023)
Figure 40 Dassault Systemes SE: Financial Overview (2023)
Figure 41 Azenta, Inc.: Financial Overview (2023)
Figure 42 F. Hoffmann-La Roche Ltd.: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
NGS Market: Industry Outlook - Global Opportunity Analysis And Industry Forecast (2024-2031)
Published Date: Jul-2024
Proteomics Market - Global Opportunity Analysis And Industry Forecast ( 2013-2018)
Published Date: Oct-2013
North America NGS Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
